ESKETAMINE
Clinical trials for ESKETAMINE explained in plain language.
Never miss a new study
Get alerted when new ESKETAMINE trials appear
Sign up with your email to follow new studies for ESKETAMINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could esketamine be the key to faster fibromyalgia pain relief?
Symptom relief Recruiting nowThis study looks at whether adding esketamine to standard fibromyalgia treatments can reduce pain more quickly and effectively. About 92 adults with fibromyalgia who haven't gotten enough relief from other treatments will take part. Researchers will compare pain levels between th…
Matched conditions: ESKETAMINE
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Could a drug combo boost Post-Surgery recovery?
Symptom relief Recruiting nowThis study tests whether giving dexmedetomidine and esketamine during and after surgery can help patients recover better. 316 adults having general anesthesia will receive one or both drugs, and their recovery quality will be measured using a 15-item questionnaire. The goal is to…
Matched conditions: ESKETAMINE
Phase: PHASE4 • Sponsor: Peking University First Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Nose spray could replace needles for Post-Surgery pain in children
Symptom relief Recruiting nowThis study tests whether a nose spray containing two drugs, dexmedetomidine and esketamine, can reduce pain after tonsil and adenoid surgery in children aged 3 to 7. About 160 kids will receive either the drug combo or a placebo spray right after anesthesia. Researchers will trac…
Matched conditions: ESKETAMINE
Phase: PHASE4 • Sponsor: Peking University First Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Could a simple drug boost ECT for depressed teens?
Symptom relief Recruiting nowThis study tests whether adding a low dose of esketamine (a fast-acting anesthetic) to standard electroconvulsive therapy (ECT) can improve depression outcomes in adolescents aged 13-17 with severe depression. About 220 participants will be randomly assigned to receive either esk…
Matched conditions: ESKETAMINE
Phase: EARLY_PHASE1 • Sponsor: Min Su • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
New nasal spray could ease Kids' surgery fears
Symptom relief Recruiting nowThis study tests a nasal spray combining two medicines (dexmedetomidine and esketamine) to help children aged 1-6 relax before surgery. The goal is to find the best dose that makes kids calm enough for a smooth start to anesthesia. About 80 children will take part to see how well…
Matched conditions: ESKETAMINE
Phase: PHASE4 • Sponsor: Second Affiliated Hospital of Wenzhou Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC